4don MSN
The demand for healthcare is going to continue to accelerate, says Abbott Labs CEO Robert Ford
Robert Ford, Abbott Laboratories chairman and CEO, joins 'Squawk Box' to discuss the state of healthcare demand, the ...
Abbott Laboratories (ABT) is bracing for the impact of higher tariffs, including a 50% US levy on its Indian imports. "Our impact between the whole network is just under $200 million," CEO Robert Ford ...
The world's first dual continuous glucose and ketone monitor is designed to help prevent diabetic ketoacidosis (DKA).
April 20 (Reuters) - Abbott Laboratories Inc's chief executive said on Wednesday it would not be appropriate to comment on whether the company was committed to buying diagnostics company Alere Inc, ...
Abbott Laboratories (NYSE:ABT) achieved double-digit earnings per share growth in 2025 despite market challenges. The company has a strong pipeline with several new product launches planned, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results